PdAu-based nanotheranostic agent for photothermal initiation and oxygen-independent free radicals generation

Feng Wang,Zhi Yu Sun,Zhuo Wang,Jia Zhou,Lining Sun

DOI: https://doi.org/10.1039/d2ce00662f

IF: 3.756

2022-01-01

CrystEngComm

Abstract:Due to a rapid proliferation of tumor cells leading to high oxygen consumption, solid tumors generally have the characteristics of hypoxia, which greatly limits the effect of photodynamic therapy sensitivity...

What problem does this paper attempt to address?

PdAu-based nanotheranostic agent for photothermally initiated and oxygen-independent free radical generation

Feng Wang,Zaoxia Sun,Zhuo Wang,Junxun Zhou,Lining Sun

DOI: https://doi.org/10.1039/d2ce00662f

IF: 3.756

2022-01-01

CrystEngComm

Abstract:Due to the rapid proliferation of tumor cells leading to high oxygen consumption, solid tumors generally have the characteristics of hypoxia, which greatly limits the effect of photodynamic therapy sensitive to oxygen levels. Here, we report the construction of a photodynamic/photothermal synergistic theranostic agent, which mainly utilizes oxygen-independent free radicals generated from a thermally decomposable free radical initiator and in situ heating to kill cancer cells, overcoming the poor tumor therapeutic effect in a hypoxic environment. In this case, the 2,2 '-azobis-[2-(2-imidazolin-2-yl)propane] dihydrochloride (AIPH) molecule, as a thermally decomposable free radical initiator, is loaded on polydopamine-coated PdAu alloy nanoparticles via pi-pi stacking (named as AIPH-PdAu@PDA). A self-assembly strategy was applied by using gadolinium-bovine serum albumin (Gd-BSA) complexes to encapsulate the AIPH-PdAu@PDA nanoparticles, resulting in the final magnetic resonance/computed tomography/photoacoustic triple-modal imaging guided and single laser (808 nm) activated photodynamic/photothermal therapy theranostic agent AIPH-PdAu@PDA@Gd-BSA, denoted as APPG. Systematic evaluations in vitro demonstrate that this interesting theranostic platform can rapidly generate high heat under irradiation from the 808 nm laser, thereby inducing the initiator AIPH molecule to produce oxygen-independent free radicals and displaying excellent triple-modal imaging performance. Therefore, the proposed triple-modal imaging-guided single laser activated synergistic therapy nanocomposite is a promising platform for imaging-guided cancer treatment.
Nanostructured Phthalocyanine Assemblies With Efficient Synergistic Effect Of Type I Photoreaction And Photothermal Action To Overcome Tumor Hypoxia In Photodynamic Therapy

Yuan-Yuan Zhao,Ling Zhang,Zixuan Chen,Bi-Yuan Zheng,Meirong Ke,Xingshu Li,Jian-Dong Huang

DOI: https://doi.org/10.1021/jacs.1c07479

IF: 15

2021-01-01

Journal of the American Chemical Society

Abstract:Most photodynamic therapy (PDT) paradigms work through the highly O-2-dependent type II photoreaction to generate singlet oxygen (O-1(2)). The hypoxic microenvironment of solid tumors severely hampers therapeutic outcomes. Here, we present a novel design that could transfer the photo-physical and photo-chemical properties of traditional phthalocyanine-based photo-sensitizers from type II photoreaction to efficient type I photoreaction and vibrational relaxation-induced photothermal conversion. These features enable the obtained nanostructured phthalocyanine assemblies (e.g., NanoPcAF) to display excellent phototherapies under both normoxic and hypoxic conditions. Moreover, NanoPcAF has a high level of accumulation in tumor tissues after intravenous injection, and 94% of tumor growth is inhibited in a preclinical model at a NanoPcAF dose of 0.8 nmol g(-1) and light dose of 300 J cm(-2).
Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

Nan Lu,Wenpei Fan,Xuan Yi,Sheng Wang,Zhantong Wang,Rui Tian,Orit Jacobson,Yijing Liu,Bryant C. Yung,Guofeng Zhang,Zhaogang Teng,Kai Yang,Minming Zhang,Gang Niu,Guangming Lu,Xiaoyuan Chen

DOI: https://doi.org/10.1021/acsnano.7b08103

IF: 17.1

2018-01-01

ACS Nano

Abstract:Alleviation of tumor hypoxia has been the premise for improving the effectiveness of radiotherapy, which hinges upon the advanced delivery and rapid release of oxygen within the tumor region. Herein, we propose a "bubble-enhanced oxygen diffusion" strategy to achieve whole tumor oxygenation for significant radiation enhancement based on the "bystander effect". Toward this end, sub-50 nm CuS-modified and 64Cu-labeled hollow mesoporous organosilica nanoparticles were constructed for tumor-specific delivery of O2-saturated perfluoropentane (PFP). Through the aid of PFP gasification arising from NIR laser-triggered mild hyperthermia, simultaneous PET/PA/US multimodality imaging and rapid oxygen diffusion across the tumor can be achieved for remarkable hypoxic radiosensitization. Furthermore, the multifunctional oxygen-carrying nanotheranostics also allow for other oxygen-dependent treatments, thus greatly advancing the development of bubble-enhanced synergistic therapy platforms.
Oxygen-independent Free Radicals Induced by Photothermal Effect of Fe3O4 for Hypoxic Cancer Therapy

Xiaofeng Wang,Xiangrong Tian,Kai Zhao,Lin Wu,Jin Cao,Song Shen

DOI: https://doi.org/10.1246/cl.220091

2022-01-01

Chemistry Letters

Abstract:Cancer treatments based on reactive oxygen species (ROS) have emerged as effective clinical methods. However, the generation of ROS is significantly suppressed owing to the hypoxic tumor microenvironment. ROS generated in an oxygen-independent manner provides a novel strategy for cancer therapy. Here, we use an initiator as therapeutic drug to realize light controlled generation of free radicals. The initiator was loaded onto Fe3O4 nanoparticles. Upon the irradiation of near infrared light, the temperature of the nanoparticles increased, inducing the decomposition of the initiator to produce alkyl radicals. This therapeutic system showed remarkable damage to cells in hypoxic environment.
Tumor microenvironment/NIR-responsive oxygen-irrelevant radical nanogenerator for hypoxia-independent photothermal-thermodynamic osteosarcoma nanotherapy

Xiangtian Deng,Yitian Wang,Renliang Zhao,Zhen Zhang,Xueling Yuan,Zilu Ge,Qian Fang,Dong Wang,Weijian Liu,Wei Lin,Guanglin Wang

DOI: https://doi.org/10.1016/j.matdes.2022.111282

2022-12-01

Abstract:Although photothermal therapy (PTT) have aroused substantial attention in the treatment of various types of tumors, the antitumor therapeutic efficacy is still unsatisfactory when using PTT alone. Very recently, oxygen-independent free-radical generation based on thermodynamic therapy (TDT) has emerged as a potential powerful therapeutic strategy for hypoxic cancer therapy. Herein, in this work, an intelligent hypoxia-independent free radical nanogenerator (CuS/AIPH@MnO2, denoted as CAM) was fabricated by in situ coating manganese dioxide (MnO2) shell onto the surface of as 2,2-azobis[2-(2-imidazolin-2-yl) propane] dihydrochloride (AIPH)-loaded mesoporous hollow mesoporous copper sulfide (CuS). The local hyperthermal generated by CAM upon NIR laser irradiation not only permitted PTT, but also promoted the disintegration of AIPH for generation of oxygen-independent free radicals, exerting the advantages of combination therapy of PTT/TDT for effective tumor ablation. Simultaneously, both in vitro and in vivo results have demonstrated the synergistic therapeutic efficacy of PTT/TDT for remarkable tumor growth inhibition. In addition, the favorable biocompatibility and low cytotoxicity of the as-synthesized nanoparticles were verified both in vitro and in vivo. Collectively, this work proposed an attractive and promising strategy in cancer therapy based on generation of oxygen-irrelevant toxic free radicals, which exhibits great potential for clinical translations in hypoxic tumor therapy.

materials science, multidisciplinary
Initiator‐Loaded Gold Nanocages As a Light‐Induced Free‐Radical Generator for Cancer Therapy

Xiao‐Qiang Wang,Fan Gao,Xian‐Zheng Zhang

DOI: https://doi.org/10.1002/ange.201703159

2017-01-01

Angewandte Chemie

Abstract:AbstractTumor hypoxia greatly suppresses the therapeutic efficacy of photodynamic therapy (PDT), mainly because the generation of toxic reactive oxygen species (ROS) in PDT is highly oxygen‐dependent. In contrast to ROS, the generation of oxygen‐irrelevant free radicals is oxygen‐independent. A new therapeutic strategy based on the light‐induced generation of free radicals for cancer therapy is reported. Initiator‐loaded gold nanocages (AuNCs) as the free‐radical generator were synthesized. Under near‐infrared light (NIR) irradiation, the plasmonic heating effect of AuNCs can induce the decomposition of the initiator to generate alkyl radicals (R.), which can elevate oxidative‐stress (OS) and cause DNA damages in cancer cells, and finally lead to apoptotic cell death under different oxygen tensions. As a proof of concept, this research opens up a new field to use various free radicals for cancer therapy.
Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy

Cheng Zhang,Wen-Jun Qin,Xue-Feng Bai,Xian-Zheng Zhang

DOI: https://doi.org/10.1016/j.nantod.2020.100960

IF: 17.4

2020-12-01

Nano Today

Abstract:<p>Photodynamic therapy (PDT) shows great potential for tumor treatment owing to its high spatiotemporal selectivity, minimal invasiveness and patient compliance. However, the therapeutic effect of PDT is seriously hindered by the tumor hypoxia in vivo. Hypoxia is a typical hallmark of the solid tumor microenvironment, which promotes the proliferation, invasion and metastasis of tumor cells. Additionally, the oxygen consumption during PDT will further aggravate the tumor hypoxia, resulting in multiple undesirable side-effects. To resolve these problems, many studies have been conducted to improve the efficacy of PDT by increasing oxygen concentration in tumor. Here, we focus on the current advances in nanomaterials-mediated tumor oxygenation via oxygen-carrying or oxygen-generating strategies to relieve tumor hypoxia. Based on the comprehensive overview, we hope these inspirations in hypoxia-associated anti-tumor therapy will provide perspectives in designing new oxygenation nanomaterials in this promising field.</p>

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Engineering tumor-oxygenated nanomaterials: advancing photodynamic therapy for cancer treatment

Tingting Zuo,Xiaodie Li,Xuan Ma,Ye Zhang,Xueru Li,Xuehai Fan,Mingze Gao,Donglin Xia,Huijun Cheng

DOI: https://doi.org/10.3389/fbioe.2024.1383930

IF: 5.7

2024-03-13

Frontiers in Bioengineering and Biotechnology

Abstract:Photodynamic therapy (PDT), a promising treatment modality, employs photosensitizers to generate cytotoxic reactive oxygen species (ROS) within localized tumor regions. This technique involves administering a photosensitizer followed by light activation in the presence of oxygen (O 2 ), resulting in cytotoxic ROS production. PDT's spatiotemporal selectivity, minimally invasive nature, and compatibility with other treatment modalities make it a compelling therapeutic approach. However, hypoxic tumor microenvironment (TME) poses a significant challenge to conventional PDT. To overcome this hurdle, various strategies have been devised, including in-situ O 2 generation, targeted O 2 delivery, tumor vasculature normalization, modulation of mitochondrial respiration, and photocatalytic O 2 generation. This review aims to provide a comprehensive overview of recent developments in designing tumor-oxygenated nanomaterials to enhance PDT efficacy. Furthermore, we delineate ongoing challenges and propose strategies to improve PDT's clinical impact in cancer treatment.

multidisciplinary sciences
Microenvironment-activated Nanoparticles for Oxygen Self-Supplemented Photodynamic Cancer Therapy.

Hang Liu,Wei Jiang,Qin Wang,Jinxing Xia,Wenhao Yu,Yucai Wang,Yanmei Wang

DOI: https://doi.org/10.1039/c9bm01537j

2020-01-01

Biomaterials Science

Abstract:Tumor hypoxia, as a hallmark of most solid tumors, poses a serious impediment to O2-dependent anticancer therapies, such as photodynamic therapy (PDT). Although utilizing nanocarriers to load and transport O2 to tumor tissues has been proved effective, the therapeutic outcomes have been impeded by the low O2 capacity and limited tumor penetration of the nanocarriers. To address these problems, we incorporated perfluorooctyl moieties into nanocarriers to improve the encapsulation of perfluorooctyl bromide via fluorophilic interactions, leading to elevated O2 capacity of the nanocarriers. Meanwhile, to enhance the tumor cell penetrating ability as well as reduce reticuloendothelial system recognition, the nanocarrier was further decorated with a cell-penetrating peptide, which was masked with a protecting group via an acid-labile amide bond for prolonged circulation time and acid-activated cell penetration. The in vitro study demonstrated that, apart from remarkably boosting the photocytoxicity of chlorin 6 (Ce6) at a low dosage, the rationally designed O2@DANPCe6+PFOB could even alleviate the pre-existing tumor hypoxia. After intravenous injection, O2@DANPCe6+PFOB exhibited significant tumor accumulation and retention, and potent tumor growth inhibition compared to traditional PDT. Overall, the O2@DANPCe6+PFOB mediated O2 self-supplemented PDT with tumor acidic microenviornment-activated cell penetration provides a promising strategy in anticancer treatment.
Aza-BODIPY-based Phototheranostic Nanoagent for Tissue Oxygen Auto-Adaptive Photodynamic/photothermal Complementary Therapy

Zhao, Meijiao,Zeng, Qin,Li, Xipeng,Xing, Da,Zhang, Tao

DOI: https://doi.org/10.1007/s12274-021-3552-3

IF: 9.9

2022-01-01

Nano Research

Abstract:Tumor oxygen spatial heterogeneity is a critical challenge for the photodynamic inhibition of solid tumors. Development of an intelligent nanoagent to initiate optimal therapeutics according to the localized oxygen levels is an effective settlement. Herein, we report an activatable nanoagent (BDP-Oxide nanoparticles (NPs)) to enable the oxygen auto-adaptive photodynamic/photothermal complementary treatment. Upon the nanoagent accumulated in the tumor region, the low extracellular pH could trigger the disassociation of the nanoagent to release the phototheranostic agent, BDP-Oxide, which will subsequently afford the fluorescence imaging-guided photodynamic oxidation after it gets into the outer oxygen-rich tumors. Along with the penetration deepening in the solid tumor, furthermore, BDP-Oxide could be reduced into BDP by the cytochrome P450 (CYP450) enzymes activated in the low oxygen tension regions of inner hypoxic tumors, which will switch on the photothermal and photoacoustic effects. Overall, the BDP-Oxide NPs-enabled photodynamic/photothermal complementary therapy significantly suppressed the solid tumor growth (inhibition rate of 94.8%). This work proposes an intelligent platform to address the oxygen partial pressure for the optimization of cancer phototherapeutics.
An NIR-II Photothermally Triggered "Oxygen Bomb" for Hypoxic Tumor Programmed Cascade Therapy

Sidi Zhang,Zhenhua Li,Qingbing Wang,Qian Liu,Wei Yuan,Wei Feng,Fuyou Li

DOI: https://doi.org/10.1002/adma.202201978

Abstract:Hypoxia, as a characteristic feature of solid tumors, has a close relationship with tumor resistance to photodynamic therapy (PDT) and chemotherapy. Perfluorocarbon (PFC) is reported to relieve hypoxic in solid tumors by acting as an oxygen carrier via several nanostructures. However, the oxygen delivery process is mostly driven by a concentration gradient, which is uncontrollable. Herein, a photothermally controlled "oxygen bomb" PSPP-Au980 -D is designed by encapsulating a PFC core within a functionalized bilayer polymer shell. Near-infrared second window photothermal agent gold nanorods with excellent photo-to-heat energy-conversion ability are fabricated on the surface of the polymer shell via an innovative modified two-step seedless ex situ growth process to thermally trigger O2 release. Then, a programmed cascade therapy strategy is customized for hypoxic orthotopic pancreatic cancer. First, PSPP-Au980 -D is irradiated by a 980 nm laser to photothermally trigger O2 infusing into the hypoxic tumor microenvironment, which is accompanied by local hyperemia and doxorubicin release. Subsequently, a 680 nm laser is used to generate singlet oxygen in the oxygenated tumor microenvironment for PDT. This choreographed programmed cascade therapy strategy will provide a new route for suppressing hypoxic tumor growth under mild conditions based on controllable and effective oxygen release.
Hyperthermia and Controllable Free Radical Coenhanced Synergistic Therapy in Hypoxia Enabled by Near-Infrared-II Light Irradiation.

Jun Yang,Rui Xie,Lili Feng,Bin Liu,Ruichan Lv,Chunxia Li,Shili Gai,Fei He,Piaoping Yang,Jun Lin

DOI: https://doi.org/10.1021/acsnano.9b05985

IF: 17.1

2019-01-01

ACS Nano

Abstract:Tumor cell metabolism and tumor blood vessel proliferation are distinct from normal cells. The resulting tumor microenvironment presents a characteristic of hypoxia, which greatly limits the generation of oxygen free radicals and affects the therapeutic effect of photodynamic therapy. Here, we developed an oxygen-independent free radical generated nanosystem (CuFeSe2-AIPH@BSA) with dual-peak absorption in both near-infrared (NIR) regions and utilized it for imaging-guided synergistic treatment. The special absorption provides the nanosystem with high photothermal conversion efficiency and favorably matched photoactivity in both I and II NIR biological windows. Upon NIR light irradiation, the generated heat could prompt AIPH release and decompose to produce oxygen-independent free radicals for killing cancer cells effectively. The contrastive research results show that the enhanced therapeutic efficacy of NIR-II over NIR-I is principally due to its deeper tissue penetration and higher maximum permission exposure that benefits from a longer wavelength. Hyperthermia effect and the production of toxic free radicals upon NIR-II laser illumination are extremely effective in triggering apoptosis and death of cancer cells in the tumor hypoxia microenvironment. The high biocompatibility and excellent anticancer efficiency of CuFeSe2-AIPH@BSA allow it to be an ideal oxygen-independent nanosystem for imaging-guided and NIR-II-mediated synergistic therapy via systemic administration.
A photo and tumor microenvironment activated nano-enzyme with enhanced ROS generation and hypoxia relief for efficient cancer therapy

Yali Chen,Yujun Cai,Xingsu Yu,Hong Xiao,Haozhe He,Zecong Xiao,Yong Wang,Xintao Shuai

DOI: https://doi.org/10.1039/d1tb01437d

IF: 7.571

2021-01-01

Journal of Materials Chemistry B

Abstract:Reactive oxygen species (ROS) mediated tumor therapy strategies have exhibited great prospects and attracted increasing attention, among which photodynamic therapy (PDT) has been well-established.

materials science, biomaterials
A Porous Bimetallic Au@Pt Core-Shell Oxygen Generator to Enhance Hypoxia-Dampened Tumor Chemotherapy Synergized with NIR-II Photothermal Therapy

Jingyu Sun,Jinping Wang,Wei Hu,Yuhao Wang,Qiang Zhang,Xiaotong Hu,Tsengming Chou,Beilu Zhang,Cosmo Gallaro,Meghan Halloran,Lyu Liang,Lei Ren,Hongjun Wang

DOI: https://doi.org/10.1021/acsnano.2c02528

IF: 17.1

2022-07-16

ACS Nano

Abstract:The characteristic hypoxia of solid tumors and inadequate oxygen supply become a key causation of the resistance to chemotherapy in cancer treatment. Herein, a bimetallic oxygen nanogenerator, i.e., porous Au@Pt core-shell nanostructures, is particularly developed to reduce the multidrug resistance by oxygenating the tumor along with synergistic chemo-photothermal therapy for efficient tumor eradication. The porous platinum (Pt) shell was able to catalyze oxygen generation from endogenous...

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
Manipulate Tumor Hypoxia for Improved Photodynamic Therapy Using Nanomaterials

Mengqi Yi,Bei Xiong,Yuyang Li,Wei Guo,Yunhan Huang,Bo Lu

DOI: https://doi.org/10.1016/j.ejmech.2022.115084

IF: 7.088

2023-01-01

European Journal of Medicinal Chemistry

Abstract:Due to its low adverse effects, minimal invasiveness, and outstanding patient compliance, photodynamic therapy (PDT) has drawn a great deal of interest, which is achieved through incomplete reduction of O-2 by a photo-sensitizer under light illumination that produces amounts of reactive oxygen species (ROS). However, tumor hypoxia significantly hinders the therapeutic effect of PDT so that tumor cells cannot be eliminated, which results in tumor cells proliferating, invading, and metastasizing. Additionally, O-2 consumption during PDT exacerbates hypoxia in tumors, leading to several adverse events after PDT treatment. In recent years, various investigations have focused on conquering or using tumor hypoxia by nanomaterials to amplify PDT efficacy, which is summarized in this review. This comprehensive review's objective is to present novel viewpoints on the advancement of oxygenation nanomaterials in this promising field, which is motivated by hypoxia-associated anti-tumor therapy.
Biomedical Engineered Nanomaterials to Alleviate Tumor Hypoxia for Enhanced Photodynamic Therapy

Chunmei Lai,Bangyue Luo,Jiangwen Shen,Jingwei Shao

DOI: https://doi.org/10.1016/j.phrs.2022.106551

IF: 10.334

2022-01-01

Pharmacological Research

Abstract:Photodynamic therapy (PDT), as a highly selective, widely applicable, and non-invasive therapeutic modality that is an alternative to radiotherapy and chemotherapy, is extensively applied to cancer therapy. Practically, the efficiency of PDT is severely hindered by the existence of hypoxia in tumor tissue. Hypoxia is a typical hallmark of malignant solid tumors, which remains an essential impediment to many current treatments, thereby leading to poor clinical prognosis after therapy. To address this issue, studies have been focused on modulating tumor hypoxia to augment the therapeutic efficacy. Although nanomaterials to relieve tumor hypoxia for enhanced PDT have been demonstrated in many research articles, a systematical summary of the role of nanomaterials in alleviating tumor hypoxia is scarce. In this review, we introduced the mechanism of PDT, and the involved therapeutic modality of PDT for ablation of tumor cells was specifically summarized. Moreover, current advances in nanomaterials-mediated tumor oxygenation via oxygen-carrying or oxygen-generation tactics to alleviate tumor hypoxia are emphasized. Based on these considerable summaries and analyses, we proposed some feasible perspectives on nanoparticle-based tumor oxygenation to ameliorate the therapeutic outcomes, which may provide some detailed information in designing new oxygenation nanomaterials in this burgeneous field.
Photothermal and enhanced chemodynamic reinforced anti-tumor therapy based on PDA@POM nanocomposites

Qingyao Meng,Wenxin Wang,Haozhe Wang,Ying Tao,Neda Anastassova,Tiedong Sun,Yuan Sun,Lei Wang

DOI: https://doi.org/10.1016/j.jcis.2024.09.160

2025-01-15

Abstract:Chemodynamic therapy (CDT) and photothermal therapy (PTT) have both demonstrated considerable efficacy in the tumor treatment individually, owing to their non-invasive nature and excellent selectivity. However, due to the propensity of tumors for metastasis and recurrence, a singular therapeutic approach falls short of achieving optimal treatment outcomes. Polydopamine (PDA) has excellent photothermal conversion ability and polyoxometalates (POMs) possess diverse enzymatic activities. Here, we synthesized PDA@POM nanospheres comprising polydopamine-coated Tungsten-based polyoxometalate (W-POM). These nanospheres leverage dual enzymatic activities that synergistically enhance both chemodynamic and photothermal therapies for tumor treatment. The PDA-mediated PTT effect enables precise tumor cell destruction, while the W-POM nanozymes catalyzes the generation of highly toxic reactive oxygen species (ROS) from hydrogen peroxide within tumor cells through a Fenton-like reaction, which mitigates tumor hypoxia and induces tumor cell death. This synergistic photothermal catalytic therapy shows enhanced efficacy in tumor suppression, providing a promising new approach for tumor treatment.
Peroxidase-like Fe3O4 nanocomposite for activatable reactive oxygen species generation and cancer theranostics

Kai Zhang,Zhou Yang,Xiangdan Meng,Yu Cao,Yuedong Zhang,Wenhao Dai,Huiting Lu,Zhaofeng Yu,Haifeng Dong,Xueji Zhang

DOI: https://doi.org/10.1039/c8qm00098k

IF: 8.6834

2018-01-01

Materials Chemistry Frontiers

Abstract:Photodynamic therapy (PDT) that utilizes apoptosis induced by reactive oxygen species (ROS) has received extensive attention in practical cancer therapy. However, the hypoxic microenvironment of solid tumors significantly limits the efficacy of therapy. Approaches that overcome the barriers to PDT in hypoxic conditions by simultaneously producing ROS exogenously and improving the oxygenation of tumors have never been studied. Herein, an activatable ROS platform was designed that uses the high reactivity of peroxidase-like Fe3O4 toward endogenous hydrogen peroxide (H2O2) to concurrently generate OH as a therapeutic agent and provide O-2 for oxygen-dependent PDT. Multifunctional chitosan-encapsulated Fe3O4 nanoparticles modified with CuS and porphyrin (FCCP NPs) were fabricated to achieve multimodal imaging and synergetic therapy. The FCCP NPs possess enhanced intrinsic peroxidase mimetic activity to produce ROS and O-2 from endogenous H2O2. Multimodal imaging in vivo, including photoacoustic imaging (PAI), magnetic resonance imaging (MRI), photoluminescence imaging (PLI), and photothermal imaging (PTI), exploits the tumor-targeting property of FCCP NPs upon intravenous injection. It can induce cancer cell death with remarkable efficiency both in vitro and in vivo via synergetic treatment with PDT and photothermal therapy (PTT). This study demonstrates the promise of the activatable generation of ROS and O-2 for PDT with nanotechnology to overcome a current deficiency in cancer therapies.
Oxygen Self‐Supplying Enzymatic Nanoplatform for Precise and Enhanced Photodynamic Therapy

Xiaohui Wang,Xiaofei Wei,Jinhua Liu,Dan He,Dandan Sun,Wei Yang,Yueying Jiao,Qi Cui

DOI: https://doi.org/10.1002/adtp.202200049

IF: 5.003

2022-07-19

Advanced Therapeutics

Abstract:Traditional oxygen‐dependent photodynamic therapy (PDT) faces formidable challenges owing to abnormal angiogenesis and insufficient oxygen supply in solid tumors. Herein, a multifunctional nanoplatform (HRP‐DPBF‐Zn) consisting of photosensitizer zinc (II) phthalocyanine (ZnPc), singlet oxygen (1O2) probe 1,3‐diphenylisobenzofuran (DPBF), and hydrogen peroxide (H2O2) catalyst horseradish peroxidase (HRP) is developed. Such HRP‐DPBF‐Zn nanosystems are expected to possess catalase‐like capacity for catalyzing intracellular H2O2 to produce oxygen (O2). The enhanced O2 content further facilitates the production of cytotoxic 1O2 by ZnPc under laser irradiation. DPBF loading endows the nanoplatform with the high 1O2 sensitivity, which can promote precise PDT with fluorescent 1O2 feedback. HRP‐DPBF‐Zn exhibits excellent biocompatibility, efficient 1O2 generation, high 1O2 sensitivity, favorable H2O2‐to‐O2 decomposition, and superior fluorescence imaging properties. Both in vitro and in vivo experimental results confirm that such HRP‐DPBF‐Zn can accomplish highly specific and efficient PDT against hypoxic tumors, which shows great potential in tumor theranostics. An O2 self‐sufficient catalase‐like nanoplatform has been designed to regulate the hypoxic tumor microenvironment for enhanced photodynamic therapy (PDT). The nanoplatform can effectively produce oxygen by the H2O2 decomposition, and implement efficient 1O2 generation and high 1O2 sensitivity. Robust in vitro and in vivo anticancer efficacy demonstrates a promising platform of PDT in tumor treatment.
Construction of a nanotheranostic system Zr-MOF@PPa/AF@PEG for improved photodynamic therapy effects based on the PDT-oxygen consumption and hypoxia sensitive chemotherapeutic drug

Xingchao Wang,Zhiqiang Wang,Wei Ma,Xiaodan Wu,Wen Fang,Changhong Guo,Yingxue Jin

DOI: https://doi.org/10.1016/j.jphotobiol.2021.112274

2021-01-01

Abstract:Photodynamic therapy (PDT) has gained much attention in tumor therapy because of its special advantages. PDT heavily depends on the oxygen, yet the tumor microenvironment (TME) is a hypoxic and acid milieu, which weakens the PDT effect. Based on the consideration that the TME deteriorated by the PDT oxygen consumption could activate the hypoxic-sensitive small-molecule drug, we designed and prepared an integrated nano composite including zirconium ion metal organic framework (carrier), pyropheophorbide-a (PPa, photosensitizer), and 6-amino flavone (AF, hypoxic-sensitive drug), aiming to exert a cascaded PDT-chemotherapy (CT) antitumor effect and to solve the hypoxic challenge. The prepared nanocomposite showed great stability under the physiological (pH 7.4) condition and could continuously release PPa and AF under slightly acidic pH condition (pH 6.4), suggesting a tumor microenvironment responsive feature. Systematical in vitro and in vivo researches under various conditions (light, dark, hypoxic and normoxic) have showed that the obtained ZrMOF@PPa/AF@PEG nanoparticles (NPs) had good biocompatibility and could achieve efficient antitumor effects based on PDT-chemotherapy (CT) cascade process. Finally, bright red fluorescence was observed in the tumor cells after internalization implying an application potential in tumor imaging.

PdAu-based nanotheranostic agent for photothermal initiation and oxygen-independent free radicals generation

PdAu-based nanotheranostic agent for photothermally initiated and oxygen-independent free radical generation

Nanostructured Phthalocyanine Assemblies With Efficient Synergistic Effect Of Type I Photoreaction And Photothermal Action To Overcome Tumor Hypoxia In Photodynamic Therapy

Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

Oxygen-independent Free Radicals Induced by Photothermal Effect of Fe3O4 for Hypoxic Cancer Therapy

Tumor microenvironment/NIR-responsive oxygen-irrelevant radical nanogenerator for hypoxia-independent photothermal-thermodynamic osteosarcoma nanotherapy

Initiator‐Loaded Gold Nanocages As a Light‐Induced Free‐Radical Generator for Cancer Therapy

Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy

Engineering tumor-oxygenated nanomaterials: advancing photodynamic therapy for cancer treatment

Microenvironment-activated Nanoparticles for Oxygen Self-Supplemented Photodynamic Cancer Therapy.

Aza-BODIPY-based Phototheranostic Nanoagent for Tissue Oxygen Auto-Adaptive Photodynamic/photothermal Complementary Therapy

An NIR-II Photothermally Triggered "Oxygen Bomb" for Hypoxic Tumor Programmed Cascade Therapy

Hyperthermia and Controllable Free Radical Coenhanced Synergistic Therapy in Hypoxia Enabled by Near-Infrared-II Light Irradiation.

A photo and tumor microenvironment activated nano-enzyme with enhanced ROS generation and hypoxia relief for efficient cancer therapy

A Porous Bimetallic Au@Pt Core-Shell Oxygen Generator to Enhance Hypoxia-Dampened Tumor Chemotherapy Synergized with NIR-II Photothermal Therapy

Manipulate Tumor Hypoxia for Improved Photodynamic Therapy Using Nanomaterials

Biomedical Engineered Nanomaterials to Alleviate Tumor Hypoxia for Enhanced Photodynamic Therapy

Photothermal and enhanced chemodynamic reinforced anti-tumor therapy based on PDA@POM nanocomposites

Peroxidase-like Fe3O4 nanocomposite for activatable reactive oxygen species generation and cancer theranostics

Oxygen Self‐Supplying Enzymatic Nanoplatform for Precise and Enhanced Photodynamic Therapy

Construction of a nanotheranostic system Zr-MOF@PPa/AF@PEG for improved photodynamic therapy effects based on the PDT-oxygen consumption and hypoxia sensitive chemotherapeutic drug